Just read about this this morning. Is anyone on this?
The U.S. Food and Drug Administration research showed early treatment with Actemra could prevent irreversible damage to joints in patients with systemic sclerosis and held stave off long-term disability. Dow Jones Business News, 06/10/2015. (Also see Scleroderma Clinical Trials)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.